Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the complete record of transactions filed by Ling Geoffrey M.D., Director. Director active across 2 companies, notably Catalyst Biosciences, INC.. In total, 9 disclosures have been recorded. History available since 1 July 2021. The latest transaction was filed on 12 January 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations
Ling Geoffrey M.D. is Administrateur at Celularity Inc and Catalyst Biosciences, INC. He has 9 filings in total, and the 9 sampled filings run from 2021-07-02 to 2026-01-15. The sampled recent filings indicate a transaction nature of Attribution, with buy and sell amounts of EUR 0.